Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2023 Feb;46(2):235-259.
doi: 10.1007/s40618-022-01877-5. Epub 2022 Sep 7.

Electrolyte imbalances as poor prognostic markers in COVID-19: a systemic review and meta-analysis

Affiliations
Meta-Analysis

Electrolyte imbalances as poor prognostic markers in COVID-19: a systemic review and meta-analysis

H J J M D Song et al. J Endocrinol Invest. 2023 Feb.

Abstract

Purpose: Serum electrolyte imbalances are highly prevalent in COVID-19 patients. However, their associations with COVID-19 outcomes are inconsistent, and of unknown prognostic value. We aim to systematically clarify the associations and prognostic accuracy of electrolyte imbalances (sodium, calcium, potassium, magnesium, chloride and phosphate) in predicting poor COVID-19 clinical outcome.

Methods: PubMed, Embase and Cochrane Library were searched. Odds of poor clinical outcome (a composite of mortality, intensive-care unit (ICU) admission, need for respiratory support and acute respiratory distress syndrome) were pooled using mixed-effects models. The associated prognostic sensitivity, positive and negative likelihood ratios (LR + , LR-) and predictive values (PPV, NPV; assuming 25% pre-test probability), and area under the curve (AUC) were computed.

Results: We included 28 observational studies from 953 records with low to moderate risk-of-bias. Hyponatremia (OR = 2.08, 95% CI = 1.48-2.94, I2 = 93%, N = 8), hypernatremia (OR = 4.32, 95% CI = 3.17-5.88, I2 = 45%, N = 7) and hypocalcemia (OR = 3.31, 95% CI = 2.24-4.88, I2 = 25%, N = 6) were associated with poor COVID-19 outcome. These associations remained significant on adjustment for covariates such as demographics and comorbidities. Hypernatremia was 97% specific in predicting poor outcome (LR + 4.0, PPV = 55%, AUC = 0.80) despite no differences in CRP and IL-6 levels between hypernatremic and normonatremic patients. Hypocalcemia was 76% sensitive in predicting poor outcome (LR- 0.44, NPV = 87%, AUC = 0.71). Overall quality of evidence ranged from very low to moderate.

Conclusion: Hyponatremia, hypernatremia and hypocalcemia are associated with poor COVID-19 clinical outcome. Hypernatremia is 97% specific for a poor outcome, and the association is independent of inflammatory marker levels. Further studies should evaluate if correcting these imbalances help improve clinical outcome.

Keywords: Death risk; Electrolytes; Hypernatremia; Intensive care; Respiratory medicine; Severe acute respiratory syndrome.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflicts of interest to declare.

Figures

Fig. 1
Fig. 1
PRISMA flow diagram of the study selection process
Fig. 2
Fig. 2
Forest plot showing the (a) unadjusted and (b) adjusted association between electrolyte imbalances with poor outcome*, stratified by the type of electrolyte imbalance. Black diamonds are the estimated pooled odds ratios for each random-effects meta-analysis; red boxes reflect the relative weight apportioned to studies in the meta-analysis.*Poor outcome Is defined as a composite of mortality, ICU admission, respiratory support and acute respiratory distress syndrome
Fig. 3
Fig. 3
Forest plot showing the pooled unadjusted odds ratios (a) and adjusted odds ratios (b) of the association between electrolyte imbalances and mortality, stratified by the type of electrolyte imbalance. Black diamonds are the estimated pooled odds ratios for each random-effects meta-analysis; blue/red boxes reflect the relative weight apportioned to studies in the meta-analysis
Fig. 4
Fig. 4
Forest plot showing the unadjusted association between electrolyte imbalances with ICU admission, stratified by the type of electrolyte imbalance. Black diamonds are the estimated pooled odds ratios for each random-effects meta-analysis; blue boxes reflect the relative weight apportioned to studies in the meta-analysis
Fig. 5
Fig. 5
Forest plot showing the a unadjusted and b adjusted association between electrolyte imbalances and respiratory support, stratified by the type of electrolyte imbalance. Black diamonds are the estimated pooled odds ratios for each random-effects meta-analysis; red boxes reflect the relative weight apportioned to studies in the meta-analysis
Fig. 6
Fig. 6
a Summary receiver operator characteristic curve, b Fagan plot and c Coupled funnel plot of hypernatremia in predicting poor outcome
Fig. 7
Fig. 7
a Summary receiver operator characteristic curve, b Fagan plot and c Coupled funnel plot of hypocalcemia in predicting poor outcome

Similar articles

Cited by

References

    1. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan. China Lancet. 2020;395:497–506. doi: 10.1016/s0140-6736(20)30183-5. - DOI - PMC - PubMed
    1. Dong E, Du H, Gardner L. An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect Dis. 2020;20:533–534. doi: 10.1016/S1473-3099(20)30120-1. - DOI - PMC - PubMed
    1. Huang I, Lim MA, Pranata R. Diabetes mellitus is associated with increased mortality and severity of disease in COVID-19 pneumonia - a systematic review, meta-analysis, and meta-regression. Diabetes Metab Syndr. 2020;14:395–403. doi: 10.1016/j.dsx.2020.04.018. - DOI - PMC - PubMed
    1. Wang B, Li R, Lu Z, Huang Y. Does comorbidity increase the risk of patients with COVID-19: evidence from meta-analysis. Aging (Albany NY) 2020;12:6049–6057. doi: 10.18632/aging.103000. - DOI - PMC - PubMed
    1. Du Y, Zhou N, Zha W, Lv Y. Hypertension is a clinically important risk factor for critical illness and mortality in COVID-19: A meta-analysis. Nutr Metab Cardiovasc Dis. 2021;31:745–755. doi: 10.1016/j.numecd.2020.12.009. - DOI - PMC - PubMed